pharmaphorum July 5, 2024
Private equity firms Bain Capital and Cinven are reported to be considering a bid for Sanofi’s consumer health business, according to Bloomberg.
Citing people familiar with the matter, the news service suggests that Advent International is also discussing a combined bid with other investors for the business, which has been valued at around $20 billion. Advent is talking with the Abu Dhabi Investment Authority on a bid, it reports, while French state investment firm Bpifrance is also exploring a possible investment.
Sanofi said last October that it was planning to spin off its consumer health business into a separate company before the end of this year and focus its efforts on its prescription drugs business. It has also started streamlining...
Today's Sponsors
Today's Sponsor